Literature DB >> 11731522

High-dose interferon versus GM2 vaccine in high-risk malignant melanoma.

K Wilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731522

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Adjuvant interferon alfa for melanoma.

Authors:  Kenneth S Wilson; Andrew Attwell
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

2.  Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma.

Authors:  Robyn D Gartrell; Douglas K Marks; Emanuelle M Rizk; Margaret Bogardus; Camille L Gérard; Luke W Barker; Yichun Fu; Camden L Esancy; Gen Li; Jiayi Ji; Shumin Rui; Marc S Ernstoff; Bret Taback; Sarabjot Pabla; Rui Chang; Sandra J Lee; John J Krolewski; Carl Morrison; Basil A Horst; Yvonne M Saenger
Journal:  Clin Cancer Res       Date:  2019-01-15       Impact factor: 12.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.